HomeInsightsStock Comparison

Bharat Immunological Biological Corporation Ltd vs Unichem Laboratories Ltd Stock Comparison

Bharat Immunological Biological Corporation Ltd vs Unichem Laboratories Ltd Stock Comparison

Last Updated on: Jul 19, 2025

Key Highlights

  • The Latest Trading Price of Bharat Immunological & Biological Corporation Ltd is ₹ 22.87 as of 18 Jul 15:30.
  • The P/E Ratio of Bharat Immunological & Biological Corporation Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Unichem Laboratories Ltd changed from 63.4 on March 2021 to 35.5 on March 2025 . This represents a CAGR of -10.95% over 5 years.
  • The Market Cap of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Unichem Laboratories Ltd changed from ₹ 1065 crore on March 2020 to ₹ 4877 crore on March 2025 . This represents a CAGR of 28.86% over 6 years.
  • The revenue of Bharat Immunological & Biological Corporation Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Unichem Laboratories Ltd for the Mar '25 is ₹ 596.43 crore as compare to the Dec '24 revenue of ₹ 546.71 crore. This represent the growth of 9.09%.
  • The ebitda of Bharat Immunological & Biological Corporation Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Unichem Laboratories Ltd for the Mar '25 is ₹ 92.95 crore as compare to the Dec '24 ebitda of ₹ 99.14 crore. This represent the decline of -6.24%.
  • The net profit of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Unichem Laboratories Ltd changed from ₹ -0.67 crore to ₹ 52.97 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Bharat Immunological & Biological Corporation Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Unichem Laboratories Ltd changed from -50 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Bharat Immunological & Biological Corporation Ltd

  • The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
  • BIBCOL was incorporated in 1989.
  • The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
  • BIBCL installed a plant of 100 mln units.
  • Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.

About Unichem Laboratories Ltd

  • Unichem Laboratories Limited manufactures active pharmaceutical ingredients.
  • The company operates through four divisions, namely Unichem Pharma Division, Unichem Specialities Division, Unisearch Division and Neu-Foreva Division.
  • The company is headquartered in Mumbai with five manufacturing facilities located at Roha in Maharashtra, Goa, Ghaziabad in Uttar Pradesh, Pithampur in Madhya Pradesh and Baddi in Himachal Pradesh. The company's facilities enjoy credible certifications, the Goa plant was approved by UK MHRA, MCC (South Africa), WHO (Geneva) and TGA (Australia).
  • The Baddi plant was approved by UK MHRA and MCC (South Africa).
  • The company received ISO 9001:2000 for all their plants and corporate office.

Bharat Immunological & Biological Corporation Ltd News Hub

News

Bharat Immunological & Biological Corporation Ltd leads losers in 'B' group

Relicab Cable Manufacturing Ltd, Precision Wires India Ltd, Brainbees Solutions Ltd and Fl...

Read more

08 Jan 2025 14:45

News

Bharat Immunological & Biological Corporation Ltd leads gainers in 'B' group

Bodhi Tree Multimedia Ltd, Mangal Credit & Fincorp Ltd, Innovana Thinklabs Ltd and Bartron...

Read more

06 Jan 2025 12:15

News

Bharat Immunological & Biolog.Corp. to hold board meeting

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

10 Aug 2024 17:28

News

Bharat Immunological & Biolog.Corp. announces board meeting date

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

01 Mar 2024 10:22

News

Bharat Immunological & Biolog.Corp. to convene AGM

Bharat Immunological & Biolog.Corp. announced that the 34th Annual General Meeting (AGM) o...

Read more

29 Nov 2023 10:47

News

Bharat Immunological & Biolog.Corp. to conduct AGM

Bharat Immunological & Biolog.Corp. announced that the 34th Annual General Meeting (AGM) o...

Read more

28 Nov 2023 18:37

Unichem Laboratories Ltd News Hub

News

Unichem Laboratories to table results

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 4 Aug...

Read more

16 Jul 2025 10:10

News

Unichem Labs slides after receiving three USFDA observations at Roha facility

In a regulatory filing, the company stated that the USFDA conducted the inspection from 16...

Read more

23 Jun 2025 09:53

News

Unichem Laboratories to convene AGM

Unichem Laboratories announced that the 62th Annual General Meeting(AGM) of the company wi...

Read more

21 Jun 2025 15:21

News

Unichem Laboratories to table results

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 22 Ma...

Read more

08 May 2025 15:32

News

Unichem Laboratories receives upgrade in credit ratings from ICRA

Unichem Laboratories announced that t ICRA, the credit rating agency has upgraded the rati...

Read more

18 Feb 2025 19:58

News

Unichem Laboratories schedules board meeting

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 6 Feb...

Read more

14 Jan 2025 14:54

SWOT Analysis Of Unichem Laboratories Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Bharat Immunological & Biological Corporation Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Unichem Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Bharat Immunological & Biological Corporation Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Bharat Immunological & Biological Corporation Ltd and Unichem Laboratories Ltd

Which company has a larger market capitalization, Bharat Immunological & Biological Corporation Ltd or Unichem Laboratories Ltd?

Market cap of Bharat Immunological & Biological Corporation Ltd is 98 Cr while Market cap of Unichem Laboratories Ltd is 4,430 Cr

What are the key factors driving the stock performance of Bharat Immunological & Biological Corporation Ltd and Unichem Laboratories Ltd?

The stock performance of Bharat Immunological & Biological Corporation Ltd and Unichem Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bharat Immunological & Biological Corporation Ltd and Unichem Laboratories Ltd?

As of July 19, 2025, the Bharat Immunological & Biological Corporation Ltd stock price is INR ₹22.87. On the other hand, Unichem Laboratories Ltd stock price is INR ₹629.25.

How do dividend payouts of Bharat Immunological & Biological Corporation Ltd and Unichem Laboratories Ltd compare?

To compare the dividend payouts of Bharat Immunological & Biological Corporation Ltd and Unichem Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions